Sign in

CIK 0000818033

  • Accelerated filer

HERON THERAPEUTICS, INC. /DE/

Sign in to watch
Ticker
HRTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
942875566
Phone
+1 858-251-4400
Business address
4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, 92121
Former names
AP PHARMA INC /DE/, ADVANCED POLYMER SYSTEMS INC /DE/
  1. 4 Grant or award Director acquired 10,452 shares (grant or award)
  2. 4 Open-market sale Director sold 250 shares at $9.73 ($2,432)
  3. 4 Grant or award Director acquired 10,452 shares (grant or award)
  4. 4 Grant or award Director acquired 10,452 shares (grant or award)
  5. 4 Shares withheld for taxes EVP, Chief Operating Officer gave up 433 shares (to pay taxes)
  6. 4 Shares withheld for taxes Chief Executive Officer gave up 963 shares (to pay taxes)
  7. 4 Shares withheld for taxes President & CCO gave up 433 shares (to pay taxes)
  8. 4 Shares withheld for taxes VP, Chief Accounting Officer gave up 191 shares (to pay taxes)
  9. 4 Shares withheld for taxes EVP, Drug Development gave up 433 shares (to pay taxes)
  10. 3 Insider Initial Statement of Ownership
  11. 3 Insider Initial Statement of Ownership
  12. 4 Open-market sale Director sold 300 shares at $12.31 ($3,692)
  13. 4 Open-market sale Director sold 250 shares at $12.30 ($3,074)
  14. 4 Other acquisition EVP, Chief Operating Officer acquired 1,530 shares (other)
  15. 4 Other acquisition Chief Executive Officer acquired 1,529 shares (other)
  16. 4 Other acquisition President & CCO acquired 971 shares (other)
  17. 4 Other acquisition VP, Chief Accounting Officer acquired 1,530 shares (other)
  18. 4 Shares withheld for taxes EVP, Drug Development gave up 433 shares (to pay taxes)
  19. 4 Open-market sale Director sold 300 shares at $15.20 ($4,559)
  20. 4 Open-market sale Director sold 250 shares at $15.20 ($3,801)

Page 10 of 30 · 585 filings